Omada Health, Inc.
Omada Health, which went public in June, said Wei-Li Shao will become CEO on Jan. 1, replacing founder Sean Duffy, who will move to executive chair. The change was announced with Q2 results. Omada reported Q2 revenue of $88 million (+43% Y/Y), profit of $5 million, gross margin of 73%, and raised 2026 revenue guidance to $334 million-$340 million.
Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 q2fy26pressrelease.htm EX-99 Document Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Becom
Cook Steven L. (Chief Financial Officer) sold 35,600 shares of Omada Health, Inc. (OMDA) at an average of $22.87 ($22.76–$23.09, $0.81M total) across 2 trades over 2026-07-01 to 2026-07-07 under a Rule 10b5-1 trading plan.
Over the past 7 days, alphai's AI scored 1 news story mentioning OMDA (Omada Health, Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent OMDA coverage spans financial news, insider activity and earnings.
In the last 30 days, OMDA insiders filed 6 SEC Form 4 transactions — no purchases and 6 sales ($720K). The most active reporter was Cook Steven L., Chief Financial Officer, with 4 filings. 100% of activity was filed under pre-arranged Rule 10b5-1 plans.
Omada Health, which went public in June, said Wei-Li Shao will become CEO on Jan. 1, replacing founder Sean Duffy, who will move to executive chair. The change was announced with Q2 results. Omada reported Q2 revenue of $88 million (+43% Y/Y), profit of $5 million, gross margin of 73%, and raised 2026 revenue guidance to $334 million-$340 million.
Raised guidance and record margins suggest improving profitability trajectory, while the CEO transition adds execution risk but also signals leadership continuity.
This is a routine insider-sale disclosure with limited signal value, but it can slightly affect near-term sentiment if traders interpret it as reduced confidence.
Routine 10b5-1 insider sale; likely limited incremental signal versus ongoing trading/positioning.
Routine 10b5-1 insider selling reduces Duffy’s stake slightly but is unlikely to signal a fundamental deterioration by itself.
alphai scores every news story that mentions OMDA with an AI model for sentiment and relevance, and aggregates insider trades from Omada Health, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Omada Health, which went public in June, said Wei-Li Shao will become CEO on Jan. 1, replacing founder Sean Duffy, who will move to executive chair. The change was announced with Q2 results. Omada reported Q2 revenue of $88 million (+43% Y/Y), profit of $5 million, gross margin of 73%, and raised 2026 revenue guidance to $334 million-$340 million.
4 min readOmada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 q2fy26pressrelease.htm EX-99 Document Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Becom
6 min readCook Steven L. (Chief Financial Officer) sold 35,600 shares of Omada Health, Inc. (OMDA) at an average of $22.87 ($22.76–$23.09, $0.81M total) across 2 trades over 2026-07-01 to 2026-07-07 under a Rule 10b5-1 trading plan.
1 min readDuffy Sean P. (Chief Executive Officer) sold 25,886 shares of Omada Health, Inc. (OMDA) at an average of $22.68 ($22.67–$22.70, $0.59M total) across 2 trades on 2026-07-01 under a Rule 10b5-1 trading plan.
1 min readOmada Health (OMDA) said CEO Sean P. Duffy sold 17,258 shares in open-market trades from June 24–26, 2026, per an SEC Form 4. The weighted-average sale price was $19.82/share, cutting his beneficial ownership from 0.6928% to 0.6638% (1,246,262 shares total). Sales were under a 10b5-1 plan adopted March 13, 2026.
4 min readCook Steven L. (Chief Financial Officer) sold 50,950 shares of Omada Health, Inc. (OMDA) at an average of $20.31 ($19.89–$21.07, $1.03M total) across 2 trades over 2026-06-26 to 2026-06-29 under a Rule 10b5-1 trading plan.
2 min readOmada Health, Inc. (OMDA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. omda-20260616 0001611115 false 0001611115 2026-06-16 2026-06-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2026 Date of Report (date of earliest ev
2 min readOMADA HEALTH ($OMDA) announced its Q1 2026 earnings, reporting $0.01 per share against an estimated loss of -$0.08, and revenue of $78.05 million, surpassing estimates by over $2.5 million. Following the report, the company's stock price increased by 9.15%. The article also details significant insider selling activity, mixed hedge fund movements with both additions and reductions, and recent analyst ratings with a median price target of $20.0.
2 min readGoldman Sachs has reaffirmed its Buy rating for Omada Health (OMDA.US) but has adjusted its price target downwards to $23. This indicates a continued positive outlook on the company's prospects despite a revised valuation.
2 min readOmada Health reported full-year revenue of $260.2 million in its 10-K filing, marking a 53% year-over-year increase, primarily driven by service expansion and a larger membership base. The company's earnings per share were $(0.35), with a net loss of $(12.78) million, which is a substantial improvement from the previous year. Margin expansion was attributed to Care Team efficiencies and continued investment in its care platform and programs.
3 min read
